18F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer

Radiotherapy and Oncology

Volumn 101, Issue 3, 2011, Pages 362-368

  Delouya, Guila ^b   Igidbashian, Levon ^b   Houle, Annie ^b   Bélair, Manon ^a   Boucher, Luc ^a   Cohade, Christian ^a   Beaulieu, Sylvain ^a   Filion, Édith J ^b   Coulombe, Genevive ^b   Hinse, Martin ^b   Martel, Charles ^b   Després, Philippe ^b   Nguyen Tan, Phuc Félix ^b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b NOTRE DAME HOSPITAL   (Canada)

Author keywords

18F FDG PET; Head and neck cancer; Lymph nodes; PET CT imaging; Target volumes delineation; Treatment planning

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; ASPIRATION BIOPSY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HEAD AND NECK CANCER; HISTOLOGY; HUMAN; LUNG ADENOCARCINOMA; LYMPH NODE; LYMPH NODE BIOPSY; MALE; PATIENT CARE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TONSILLECTOMY; TREATMENT PLANNING; TUMOR VOLUME; HEAD AND NECK TUMOR; IMAGE GUIDED RADIOTHERAPY; LYMPH NODE METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; SCINTISCANNING;

CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY, IMAGE-GUIDED; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 81855201960     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.07.025     Document Type: Article

References (72)

1. J. Bernier, E.J. Hall, and A. Giaccia Radiation oncology: a century of achievements Nat Rev Cancer 4 2004 737 747
2. C. Nutting, D.P. Dearnaley, and S. Webb Intensity modulated radiation therapy: a clinical review Br J Radiol 73 2000 459 469
3. A. Eisbruch, L.A. Dawson, and H.M. Kim Conformal and intensity modulated irradiation of head and neck cancer: the potential for improved target irradiation, salivary gland function, and quality of life Acta Otorhinolaryngol Belg 53 1999 271 275
4. Q. Wu, M. Manning, R. Schmidt-Ullrich, and R. Mohan The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study Int J Radiat Oncol Biol Phys 46 2000 195 205
5. T.D. Poeppel, B.J. Krause, T.A. Heusner, C. Boy, A. Bockisch, and G. Antoch PET/CT for the staging and follow-up of patients with malignancies Eur J Radiol 70 2009 382 392
6. I.F. Ciernik, E. Dizendorf, and B.G. Baumert Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study Int J Radiat Oncol Biol Phys 57 2003 853 863
7. D.E. Heron, R.S. Andrade, and J. Flickinger Hybrid PET-CT simulation for radiation treatment planning in head and neck cancers: a brief technical report Int J Radiat Oncol Biol Phys 60 2004 1419 1424
8. A.C. Paulino, M. Koshy, R. Howell, D. Schuster, and L.W. Davis Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head and neck cancer Int J Radiat Oncol Biol Phys 61 2005 1385 1392
9. D. Wang, C.J. Schultz, and P.A. Jursinic Initial experience of FDG-PET/CT guided IMRT of head and neck carcinoma Int J Radiat Oncol Biol Phys 65 2006 143 151
10. 18F-FDG-PET/CT imaging in radiotherapy target delineation for head and neck cancer Int J Radiat Oncol Biol Phys 73 2009 759 763
11. A. van Baardwijk, B.G. Baumert, and G. Bosmans The current status of FDG-PET in tumour volume definition in radiotherapy treatment planning Cancer Treat Rev 32 2006 245 260
12. C. Scarfone, W.C. Lavely, and A.J. Cmelak Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging J Nucl Med 45 2004 543 552
13. 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas Int J Radiat Oncol Biol Phys 53 2002 1051 1057
14. J.F. Daisne, T. Duprez, and B. Weynand Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen Radiology 233 2004 93 100
15. D.M. Gor, J.E. Langer, and L.A. Loevner Imaging of cervical lymph nodes in head and neck cancer: the basics Radiol Clin North Am 44 2006 101 110 viii
16. J.W. Braams, J. Pruim, and N.J. Freling Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI J Nucl Med 36 1995 211 216
17. C. Laubenbacher, D. Saumweber, and C. Wagner-Manslau Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas J Nucl Med 36 1995 1747 1757
18. C.H. Kao, S.P. ChangLai, P.U. Chieng, R.F. Yen, and T.C. Yen Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with 18-fluoro-2-deoxyglucose positron emission tomography and comparison with computed tomography J Clin Oncol 16 1998 3550 3555
19. R.J. Wong, D.T. Lin, and H. Schoder Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma J Clin Oncol 20 2002 4199 4208
20. E. Brun, E. Kjellen, and J. Tennvall FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma Head Neck 24 2002 127 135
21. E. Di Martino, B. Nowak, and H.A. Hassan Diagnosis and staging of head and neck cancer: a comparison of modern imaging modalities (positron emission tomography, computed tomography, color-coded duplex sonography) with panendoscopic and histopathologic findings Arch Otolaryngol Head Neck Surg 126 2000 1457 1461
22. C. Garcia, and P. Flamen Role of positron emission tomography in the management of head and neck cancer in the molecular therapy era Curr Opin Oncol 20 2008 275 279
23. E.M. Rohren, T.G. Turkington, and R.E. Coleman Clinical applications of PET in oncology Radiology 231 2004 305 332
24. M. Koshy, A.C. Paulino, R. Howell, D. Schuster, R. Halkar, and L.W. Davis F-18 FDG PET-CT fusion in radiotherapy treatment planning for head and neck cancer Head Neck 27 2005 494 502
25. C.C. Ling, J. Humm, and S. Larson Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality Int J Radiat Oncol Biol Phys 47 2000 551 560
26. P.H. Ahn, and M.K. Garg Positron emission tomography/computed tomography for target delineation in head and neck cancers Semin Nucl Med 38 2008 141 148
27. K. Newbold, M. Partridge, and G. Cook Advanced imaging applied to radiotherapy planning in head and neck cancer: a clinical review Br J Radiol 79 2006 554 561
28. V. Gregoire, K. Haustermans, X. Geets, S. Roels, and M. Lonneux PET-based treatment planning in radiotherapy: a new standard? J Nucl Med 48 2007 68S 77S
29. S.L. Faria, S. Menard, and S. Devic Impact of FDG-PET/CT on radiotherapy volume delineation in non-small-cell lung cancer and correlation of imaging stage with pathologic findings Int J Radiat Oncol Biol Phys 70 2008 1035 1038
30. C. Greco, K. Rosenzweig, G.L. Cascini, and O. Tamburrini Current status of PET/CT for tumour volume definition in radiotherapy treatment planning for non-small cell lung cancer (NSCLC) Lung cancer 57 2007 125 134
31. D. De Ruysscher, S. Wanders, and A. Minken Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: a planning study Radiother Oncol 77 2005 5 10
32. M. MacManus, U. Nestle, and K.E. Rosenzweig Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007 Radiother Oncol 91 2009 85 94
33. 18FDG] PET-CT-based intensity-modulated radiotherapy treatment planning of head and neck cancer Int J Radiat Oncol Biol Phys 69 2007 286 293
34. X. Geets, J.A. Lee, P. Castadot, A. Bol, and V. Gregoire Potential place of FDG-PET for the GTV delineation in head and neck and lung cancers Cancer Radiother 13 2009 594 599
35. L. Deantonio, D. Beldi, and G. Gambaro FDG-PET/CT imaging for staging, radiotherapy treatment planning of head, neck carcinoma Radiat Oncol 3 2008 29
36. J.F. Daisne, M. Sibomana, A. Bol, T. Doumont, M. Lonneux, and V. Gregoire Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of reconstruction algorithms Radiother Oncol 69 2003 247 250
37. H. Schoder, Y.E. Erdi, K. Chao, M. Gonen, S.M. Larson, and H.W. Yeung Clinical implications of different image reconstruction parameters for interpretation of whole-body PET studies in cancer patients J Nucl Med 45 2004 559 566
38. J.A. Thie Understanding the standardized uptake value, its methods, and implications for usage J Nucl Med 45 2004 1431 1434
39. R. Boellaard, N.C. Krak, O.S. Hoekstra, and A.A. Lammertsma Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study J Nucl Med 45 2004 1519 1527
40. 18F]-2-fluoro-2-deoxy-d-glucose and positron emission tomography: an overview of different analytical methods Eur J Nucl Med 27 2000 731 743
41. S. Beaulieu, P. Kinahan, and J. Tseng SUV varies with time after injection in (18)F-FDG PET of breast cancer: characterization and method to adjust for time differences J Nucl Med 44 2003 1044 1050
42. M.E. Hebert, V.J. Lowe, J.M. Hoffman, E.F. Patz, and M.S. Anscher Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: preliminary findings Am J Clin Oncol 19 1996 416 421
43. 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer Lung cancer 19 1998 167 177
44. 18F-Deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis Int J Radiat Oncol Biol Phys 44 1999 593 597
45. 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-small cell lung cancer J Nucl Med 46 2005 1342 1348
46. 18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer Q J Nucl Med Mol Imaging 49 2005 259 266
47. A.C. Riegel, A.M. Berson, and S. Destian Variability of gross tumor volume delineation in head and neck cancer using CT and PET/CT fusion Int J Radiat Oncol Biol Phys 65 2006 726 732
48. R. Hong, J. Halama, D. Bova, A. Sethi, and B. Emami Correlation of PET standard uptake value and CT window-level thresholds for target delineation in CT-based radiation treatment planning Int J Radiat Oncol Biol Phys 67 2007 720 726
49. A.C. Paulino, and P.A. Johnstone FDG-PET in radiotherapy treatment planning: Pandora's box? Int J Radiat Oncol Biol Phys 59 2004 4 5
50. J. Bradley, W.L. Thorstad, and S. Mutic Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer Int J Radiat Oncol Biol Phys 59 2004 78 86
51. E. Brianzoni, G. Rossi, and S. Ancidei Radiotherapy planning: PET/CT scanner performances in the definition of gross tumour volume and clinical target volume Eur J Nucl Med Mol Imaging 32 2005 1392 1399
52. P. Giraud, D. Grahek, and F. Montravers CT and (18)F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers Int J Radiat Oncol Biol Phys 49 2001 1249 1257
53. K. Mah, C.B. Caldwell, and Y.C. Ung The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study Int J Radiat Oncol Biol Phys 52 2002 339 350
54. T.R. Miller, and P.W. Grigsby Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy Int J Radiat Oncol Biol Phys 53 2002 353 359
55. H. Ashamalla, A. Guirgius, and E. Bieniek The impact of positron emission tomography/computed tomography in edge delineation of gross tumor volume for head and neck cancers Int J Radiat Oncol Biol Phys 68 2007 388 395
56. J.A. Lee Segmentation of positron emission tomography images: some recommendations for target delineation in radiation oncology Radiother Oncol 96 2010 302 307
57. R. Jeganathan, J. McGuigan, F. Campbell, and T. Lynch Does pre-operative estimation of oesophageal tumour metabolic length using 18F-fluorodeoxyglucose PET/CT images compare with surgical pathology length? Eur J Nucl Med Mol Imaging 38 2011 656 662
58. R.J. Burri, B. Rangaswamy, and L. Kostakoglu Correlation of positron emission tomography standard uptake value and pathologic specimen size in cancer of the head and neck Int J Radiat Oncol Biol Phys 71 2008 682 688
59. V. Ciocca, M.C. Miller, W.M. Keane, and M. Bibbo Correlation of positron emission tomography with fine needle aspiration biopsies in head and neck malignancy Acta Cytol 54 2010 5 11
60. B.T. Collins, L.J. Gardner, A.K. Verma, V.J. Lowe, F.R. Dunphy, and J.H. Boyd Correlation of fine needle aspiration biopsy and fluoride-18 fluorodeoxyglucose positron emission tomography in the assessment of locally recurrent and metastatic head and neck neoplasia Acta Cytol 42 1998 1325 1329
61. M. Yao, P. Luo, and H.T. Hoffman Pathology and FDG PET correlation of residual lymph nodes in head and neck cancer after radiation treatment Am J Clin Oncol 30 2007 264 270
62. I.A. el Hag, L.C. Chiedozi, F.A. al Reyees, and S.M. Kollur Fine needle aspiration cytology of head and neck masses. Seven years' experience in a secondary care hospital Acta Cytol 47 2003 387 392
63. Z. Tatomirovic, V. Skuletic, and R. Bokun Fine needle aspiration cytology in the diagnosis of head and neck masses: accuracy and diagnostic problems J BUON 14 2009 653 659
64. A. Hannah, A.M. Scott, and H. Tochon-Danguy Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer Ann Surg 236 2002 208 217
65. Y. Yamazaki, M. Saitoh, and K. Notani Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer Ann Nucl Med 22 2008 177 184
66. 18F-Fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis J Natl Cancer Inst 100 2008 712 720
67. M. Lonneux, M. Hamoir, and H. Reychler Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study J Clin Oncol 28 2010 1190 1195
68. E.G. Troost, D.A. Schinagl, J. Bussink, W.J. Oyen, and J.H. Kaanders Clinical evidence on PET-CT for radiation therapy planning in head and neck tumours Radiother Oncol 96 2010 328 334
69. 18F PET signals for automatic target volume definition in radiotherapy treatment planning Radiother Oncol 80 2006 43 50
70. D. Thorwarth, X. Geets, and M. Paiusco Physical radiotherapy treatment planning based on functional PET/CT data Radiother Oncol 96 2010 317 324
71. G. Petralia, L. Preda, and G. Giugliano Perfusion computed tomography for monitoring induction chemotherapy in patients with squamous cell carcinoma of the upper aerodigestive tract: correlation between changes in tumor perfusion and tumor volume J Comput Assist Tomogr 33 2009 552 559
72. S. Bisdas, Z. Rumboldt, and K. Surlan-Popovic Perfusion CT in squamous cell carcinoma of the upper aerodigestive tract: long-term predictive value of baseline perfusion CT measurements AJNR Am J Neuroradiol 31 2010 576 581